Literature DB >> 24589091

Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH.

K M J Devreese1, S S Pierangeli, B de Laat, A Tripodi, T Atsumi, T L Ortel.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24589091     DOI： 10.1111/jth.12537

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  27 in total

Review 1.  The Laboratory Diagnosis of the Antiphospholipid Syndrome.

Authors:  Jasmina Ahluwalia; Sreejesh Sreedharanunni
Journal:  Indian J Hematol Blood Transfus       Date:  2016-10-22       Impact factor: 0.900

2.  Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban.

Authors:  Ida Martinelli; Maria Abbattista; Paolo Bucciarelli; Armando Tripodi; Andrea Artoni; Francesca Gianniello; Cristina Novembrino; Flora Peyvandi
Journal:  Haematologica       Date:  2018-03-08       Impact factor: 9.941

3.  Expression of tissue factor mRNA in thrombosis associated with antiphospholipid syndrome.

Authors:  Bruna de Moraes Mazetto; Mariana Lazarini; Lais Quinteiro Tobaldini; Fernanda Talge Arantes; Ana Paula Rosa Dos Santos; Bruna Cardoso Jacinto; Camila de Oliveira Vaz; Gabriela Tripiquia Vechiatto Mesquita; Sabrina da Silva Saraiva; Joyce Annichino-Bizzacchi; Fernanda Andrade Orsi
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

Review 4.  Thrombophilia testing in the era of direct oral anticoagulants.

Authors:  Jennifer Darlow; Holly Mould
Journal:  Clin Med (Lond)       Date:  2021-09-07       Impact factor: 5.410

Review 5.  Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances.

Authors:  Arne Vandevelde; Katrien M J Devreese
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

Review 6.  Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.

Authors:  Amelia Ruffatti; Ariela Hoxha; Maria Favaro; Marta Tonello; Anna Colpo; Umberto Cucchini; Alessandra Banzato; Vittorio Pengo
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

7.  Performance Evaluation and Clinical Associations of Immunoassays That Detect Antibodies to Negatively Charged Phospholipids Other Than Cardiolipin.

Authors:  Amaris Castanon; Grant Pierre; Rohan Willis; E Nigel Harris; Elizabeth Papalardo; Zurina Romay-Penabad; Alvaro Schleh; Praveen Jajoria; Monica Smikle; Karel DeCeulaer; Anne Tebo; Troy Jaskowski; Marta M Guerra; D Ware Branch; Jane E Salmon; Michelle Petri; Emilio B Gonzalez
Journal:  Am J Clin Pathol       Date:  2018-03-29       Impact factor: 2.493

8.  Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases.

Authors:  Cecilia Nalli; Valentina Somma; Laura Andreoli; Thomas Büttner; Peter Schierack; Michael Mahler; Dirk Roggenbuck; Angela Tincani
Journal:  Auto Immun Highlights       Date:  2018-05-29

9.  Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress.

Authors:  Robert Ariens; Cecilia Becattini; Markus Bender; Wolfgang Bergmeier; Elisabetta Castoldi; Katrien Devreese; Martin Ellis; David Gailani; Vera Ignjatovic; Paula D James; Steven Kerrigan; Michele Lambert; Lai Heng Lee; Marcel Levi; Norma Maugeri; Joost Meijers; Juan Melero-Martin; Alan D Michelson; Federico Mingozzi; Keith Neeves; Heyu Ni; Anna-Karin Olsson; Zoltán Prohászka; Marie Ranson; Nicoletta Riva; Yotis Senis; Cornelia H van Ommen; Douglas E Vaughan; John Weisel
Journal:  Res Pract Thromb Haemost       Date:  2020-07-12

10.  Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.

Authors:  Dirk Roggenbuck; Maria Orietta Borghi; Valentina Somma; Thomas Büttner; Peter Schierack; Katja Hanack; Claudia Grossi; Caterina Bodio; Paolo Macor; Philipp von Landenberg; Francesco Boccellato; Michael Mahler; Pier Luigi Meroni
Journal:  Arthritis Res Ther       Date:  2016-05-21       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.